JB Pharma Q3 FY23 records 32% revenue growth
JB Pharma's revenue jumped to INR 793 crores, and Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering a growth of 26%
JB Pharma's revenue jumped to INR 793 crores, and Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering a growth of 26%
SVP Global has improved in operations with substantial improvement in EBITDA margins even after very high raw cotton prices.